spironolactone
- Product NDC
- 70518-2585
- 11-digit product format
- 705182585
- Labeler code
- 70518
- Product ID
- 70518-2585_ed202694-bf30-be2b-e053-2995a90a7564
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- spironolactone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA205936
- Marketing category
- ANDA
- Marketing start
- 2020-02-17
- Marketing end
- 0000-00-00
- Substance
- SPIRONOLACTONE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2585 | SPIRONOLACTONE TABLET [REMEDYREPACK INC.] | 11 | Legacy NDC | 20250322_41d7ab85-4bde-474a-addc-3f375a0b02b7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2585-0 | 70518258500 | 30 TABLET in 1 BLISTER PACK (70518-2585-0) | 30 tablet | 2020-02-17 | 0000-00-00 | No | No | Current |
| 70518-2585-1 | 70518258501 | 30 TABLET in 1 BLISTER PACK (70518-2585-1) | 30 tablet | 2022-01-20 | 0000-00-00 | No | No | Current |